NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/14/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization13.18 mln
Float13.73 mln
Earnings Date11/05/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
37.63
Highly suspicious
Relative Strength
3
/ 100
Severely lagging
Debt / Equity
-1.82
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Daré Bioscience Inc. is a San Diego-based company founded in 2015 that focuses on developing medical treatments for women's health, including contraception, fertility, menopause, pelvic pain, and vaginal and sexual health. Its marketed product, XACIATO, is an antibacterial gel used to treat bacterial vaginosis, while its broad pipeline includes hormone-free contraceptives, pain relief treatments, menopause therapies, and solutions for HPV-related conditions. The company also pursues innovations in preterm birth prevention, fertility support, and non-hormonal contraception for both men and women.
